Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06574971 · ClinicalTrials.gov registry record · NA

Pre-Post Intervention Study to Investigate the Safety, Feasibility, & Efficacy of the NeurGear ZenBud System for the Treatment of Anxiety & Anxiety-Related Symptoms

A NA study of Anxiety Disorders, sponsored by NeurGear.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06574971 is a NA study of Anxiety Disorders that is active but no longer recruiting, run by NeurGear. The registered enrollment target is 30 participants, below the 1,140-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06574971, a NA study of Anxiety Disorders, is active but no longer recruiting, sponsored by NeurGear.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if low intensity fodused ultrasound stiulation delivered to the auricular branch of the vagus nerve works to mitigate symptoms of anxiety disorder in adults. It will also learn about the safety and feasibility of low intensity focused ultrasound stimulation. The main questions it aims to answer are: Is low intensity ultrasound applied to the auricular branch of the vagus nerve effective for reducing the symptoms of anxiety disorders? Is low intensity ultrasound applied to the auricular branch of the vagus nerve effective for improving quality of life and sleep for individuals who suffer from anxiety disorders? Is low intensity ultrasound applied to the auricular branch of the vagus nerve effective for reducing the symptoms of depression for individuals who suffer from anxiety disorders? Is the Neurgear Zenbud a safe, accessible, and feasible way of treatment for individuals who suffer from anxiety disorders? Participants will: Use the ZenBud device, a wearable low intensity focused ultrasound delivery device, for 5 minutes a day, every day for 4 weeks Complete a weekly Becks Anxiety Inventory, Becks, Depression Inventory, Pittsburgh Sleep Quality Index questionnaire, and PCL-5 weekly Complete a post study survey asking questions about subjective efficacy and quality of life improvements.

Conditions Studied

Interventions

  • DEVICE Low intensity focused ultrasound using the NeurGear Zenbud

Study Locations (1)

New York

  • NeurGear - Rochester

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-08-15
Est. Completion 2025-08-15
Phase NA

Sponsor

NeurGear

1 total trials

What the Registry Record Tells You About NCT06574971

The ClinicalTrials.gov registry entry for NCT06574971 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,140-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (97% lower). The listed sponsor is NeurGear, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Low intensity focused ultrasound using the NeurGear Zenbud is the first listed.

NCT06574971 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06574971 about?

NCT06574971 is a clinical study titled "Pre-Post Intervention Study to Investigate the Safety, Feasibility, & Efficacy of the NeurGear ZenBud System for the Treatment of Anxiety & Anxiety-Related Symptoms". The goal of this clinical trial is to learn if low intensity fodused ultrasound stiulation delivered to the auricular branch of the vagus nerve works to mitigate symptoms of anxiety disorder in adults. It will also learn about the safety and feasibility of low intensity focused ultrasound stimulatio...

What is the current status of trial NCT06574971?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-15. Estimated completion is 2025-08-15.

What conditions does trial NCT06574971 study?

This clinical trial studies the following conditions: Anxiety Disorders.

What interventions are being tested in trial NCT06574971?

The interventions under investigation include: Low intensity focused ultrasound using the NeurGear Zenbud (DEVICE).

Who is sponsoring clinical trial NCT06574971?

This trial is sponsored by NeurGear, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06574971 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.